Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Angios Logo
Angios CB Rank
756459
Heat Score
49
Angios is a biotechnology company, specializing in vascular research to provide solutions for diabetic retinopathy.
Founded
obfuscation
Private Innsbruck, Tirol, Austria1-10 www.angios-bio.com
Biotechnology
Health Care
Medical
Overview

Angios
Heat Score
49

Growth Score
pts
in past quarter
Heat Score 49
-35 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Angios

CB Rank
756459
Angios is a biotechnology company, specializing in vascular research to provide solutions for diabetic retinopathy.
Founded
obfuscation
Private Innsbruck, Tirol, Austria1-10 www.angios-bio.com
Biotechnology
Health Care
Medical

Key People

Details

Legal Name Angios GmbH
Operating Status Active
Company Type For Profit
Founders  Gregor Wick
Phone Number 43 512 319 76 2
Contact Email office@angios-bio.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Blood Vessel Organoids Drug Screening Platform
An in vitro organoid model used to assess and predict vascular toxicity of drug candidates without animal testing.
Antibody Therapeutics for Diabetic Retinopathy
Development of novel antibody treatments targeting diabetic retinopathy and diabetic macular edema in partnership with AbCellera Biologics.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Contacts 1

Employee Profiles

News
Technology
View Tech Report

IT Spend

$69.5KThis year, Angios is projected to spend $69.5K on IT, according to Aberdeen.

Active Website Tech Count

3Angios is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Facebook Sharer.

Total IP

1Angios has 1 registered trademark in the 'Pharmaceutical, veterinary and sanitary products' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Angios's headquarters? Angios is located in Innsbruck, Tirol, Austria.Who are Angios's competitors? Alternatives and possible competitors to Angios may include Roche, Regeneron, and  Lineage Cell Therapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(55a1db1 1)
|